A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01496495
Recruitment Status : Completed
First Posted : December 21, 2011
Last Update Posted : December 30, 2014
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2014
  Study Completion Date : No date given